Early Treatment With Ivermectin and LosarTAN for Cancer Patients With COVID-19 Infection
Clinical trial NCT04447235 · TERMINATED
Trial details
- NCT number
- NCT04447235
- Sponsor
- Instituto do Cancer do Estado de São Paulo
- Status
- TERMINATED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-07-23
- Primary completion
- 2022-06-30
- Enrollment
- 77
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.